$SXTP

$0.87 -$0.00 (0.25%) Close

$SXTP Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 3.5M shares outstanding

Who owns SXTP?

By type of holder

Institutions 9.9% Insiders 13.1% Everyone else 77.0%

Concentration Top 10 holders own 23.0%

Dow Geoffrey S 9.1% · Kathmere Capital Management, LLC 7.5%

Institutional ownership

9.9%

+4.4 pts vs last qtr

Institutional holders

0 vs last qtr

Net shares bought

+155.0K

by institutions in Q2 2026

New / sold out

3 / 3

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Kathmere Capital Management, LLC +120.4K
Citadel Advisors LLC NEW +22.4K

Biggest sellers in Q2 2026

UBS Group AG −17.8K
Geode Capital Management, LLC −1.7K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for 60 Degrees Pharmaceuticals Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2023–FY2025

+236.9%

+83.54% a year

Each share's claim on the business

−70.3%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $213K

over 3 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years8% Under 1 year92%

Quarterly turnover

50.4%

of institutional shares changed hands

Top 10 managers, median time held

2 quarters

Super Investors

Investment managers reporting SXTP on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
KC Kathmere Capital Management, LLC	265.1K	7.54%	+120.4K (+83.2%)	Q1 '26	0.0%
Shares held by quarter Peak holding265.1K (Q2'26) Change over 8 quarters+265.1K Share of the company7.540% Kathmere Capital Management, LLC's full portfolio →
UG UBS Group AG	13.6K	0.39%	−17.8K (−56.7%)	2024	0.0%
Shares held by quarter Peak holding31.4K (Q1'26) Change over 8 quarters+10.3K Share of the company0.390% UBS Group AG's full portfolio →

Kathmere Capital Management, LLC

265.1K

% of company

7.54%

Change vs last qtr

+120.4K (+83.2%)

Held since

Q1 '26

UBS Group AG

13.6K

% of company

0.39%

Change vs last qtr

−17.8K (−56.7%)

Held since

2024

9 more super investors behind a free account

See every manager holding 60 Degrees Pharmaceuticals Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting SXTP on Form N-PORT; together they hold 0.4% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
FE Fidelity Extended Market Index Fund Fidelity Concord Street Trust	$15.5K	14.4K	0.41%	0.00%	August 31, 2026
FS Fidelity Series Total Market Index Fund Fidelity Concord Street Trust	$1.74K	559	0.02%	0.00%	February 28, 2026

Fidelity Extended Market Index Fund

Fidelity Concord Street Trust

Position value

$15.5K

% of company

0.41%

% of the fund

0.00%

As of

August 31, 2026

Fidelity Series Total Market Index Fund

Fidelity Concord Street Trust

Position value

$1.74K

% of company

0.02%

% of the fund

0.00%

As of

February 28, 2026

1 more funds behind a free account

See every fund holding 60 Degrees Pharmaceuticals Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
DG Dow Geoffrey S Insider	321.2K	9.13%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company9.130% Dow Geoffrey S's insider activity →
MT Miller Tyrone Insider	79.1K	2.25%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company2.250% Miller Tyrone's insider activity →

Dow Geoffrey S

Insider

321.2K

% of company

9.13%

Change vs last qtr

—

Held since

—

Miller Tyrone

Insider

79.1K

% of company

2.25%

Change vs last qtr

—

Held since

—

2 more holders behind a free account

See every insider and 5%+ holder of 60 Degrees Pharmaceuticals Inc.

Comments